Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KH901 intratumoral injection plus PF chemotherapy in head and neck cancer
CTR20131834Phase 2Active
- Sponsor
- PharmaGene
- Start
- Mar 2014
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of KH901 in head and neck cancer (HNC), nasopharyngeal carcinoma (NPC), sponsored by PharmaGene. Started Mar 2014; status: active.
02
Drugs
KH901
03
Conditions
head and neck cancer (HNC)nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on CTR20131834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131834.